Cargando…
Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus
Impaired health-related quality of life (HRQoL) is a major problem in patients with systemic lupus erythematosus (SLE). Antimalarial agents (AMA) are the cornerstone of SLE therapy, but data on their impact on HRQoL are scarce. We investigated this impact using baseline data from the BLISS-52 (NCT00...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355692/ https://www.ncbi.nlm.nih.gov/pubmed/32532059 http://dx.doi.org/10.3390/jcm9061813 |
_version_ | 1783558335303254016 |
---|---|
author | Gomez, Alvaro Soukka, Sofia Johansson, Petter Åkerström, Emil Emamikia, Sharzad Enman, Yvonne Chatzidionysiou, Katerina Parodis, Ioannis |
author_facet | Gomez, Alvaro Soukka, Sofia Johansson, Petter Åkerström, Emil Emamikia, Sharzad Enman, Yvonne Chatzidionysiou, Katerina Parodis, Ioannis |
author_sort | Gomez, Alvaro |
collection | PubMed |
description | Impaired health-related quality of life (HRQoL) is a major problem in patients with systemic lupus erythematosus (SLE). Antimalarial agents (AMA) are the cornerstone of SLE therapy, but data on their impact on HRQoL are scarce. We investigated this impact using baseline data from the BLISS-52 (NCT00424476) and BLISS-76 (NCT00410384) trials (n = 1684). HRQoL was self-reported using the Medical Outcomes Study short-form 36 (SF-36), functional assessment of chronic illness therapy (FACIT)-Fatigue and 3-level EuroQoL 5-Dimension (EQ-5D) questionnaires. Patients on AMA (n = 1098/1684) performed better with regard to SF-36 physical component summary, physical functioning, role physical, bodily pain, FACIT-Fatigue, EQ-5D utility index and EQ-5D visual analogue scale scores. The difference in SF-36 physical functioning (mean ± standard deviation (SD): 61.1 ± 24.9 versus 55.0 ± 26.5; p < 0.001) exceeded the minimal clinically important difference (≥5.0). This association remained significant after adjustment for potential confounding factors in linear regression models (standardised coefficient, β = 0.07; p = 0.002). Greater proportions of AMA users than non-users reported no problems in the mobility, self-care, usual activities and anxiety/depression EQ-5D dimensions. AMA use was particularly associated with favourable HRQoL in physical aspects among patients with active mucocutaneous and musculoskeletal disease, and mental aspects among patients with active renal SLE. These results provide support in motivating adherence to AMA therapy. Exploration of causality in the relationship between AMA use and favourable HRQoL in SLE has merit. |
format | Online Article Text |
id | pubmed-7355692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73556922020-07-23 Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus Gomez, Alvaro Soukka, Sofia Johansson, Petter Åkerström, Emil Emamikia, Sharzad Enman, Yvonne Chatzidionysiou, Katerina Parodis, Ioannis J Clin Med Article Impaired health-related quality of life (HRQoL) is a major problem in patients with systemic lupus erythematosus (SLE). Antimalarial agents (AMA) are the cornerstone of SLE therapy, but data on their impact on HRQoL are scarce. We investigated this impact using baseline data from the BLISS-52 (NCT00424476) and BLISS-76 (NCT00410384) trials (n = 1684). HRQoL was self-reported using the Medical Outcomes Study short-form 36 (SF-36), functional assessment of chronic illness therapy (FACIT)-Fatigue and 3-level EuroQoL 5-Dimension (EQ-5D) questionnaires. Patients on AMA (n = 1098/1684) performed better with regard to SF-36 physical component summary, physical functioning, role physical, bodily pain, FACIT-Fatigue, EQ-5D utility index and EQ-5D visual analogue scale scores. The difference in SF-36 physical functioning (mean ± standard deviation (SD): 61.1 ± 24.9 versus 55.0 ± 26.5; p < 0.001) exceeded the minimal clinically important difference (≥5.0). This association remained significant after adjustment for potential confounding factors in linear regression models (standardised coefficient, β = 0.07; p = 0.002). Greater proportions of AMA users than non-users reported no problems in the mobility, self-care, usual activities and anxiety/depression EQ-5D dimensions. AMA use was particularly associated with favourable HRQoL in physical aspects among patients with active mucocutaneous and musculoskeletal disease, and mental aspects among patients with active renal SLE. These results provide support in motivating adherence to AMA therapy. Exploration of causality in the relationship between AMA use and favourable HRQoL in SLE has merit. MDPI 2020-06-10 /pmc/articles/PMC7355692/ /pubmed/32532059 http://dx.doi.org/10.3390/jcm9061813 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gomez, Alvaro Soukka, Sofia Johansson, Petter Åkerström, Emil Emamikia, Sharzad Enman, Yvonne Chatzidionysiou, Katerina Parodis, Ioannis Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus |
title | Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus |
title_full | Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus |
title_fullStr | Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus |
title_full_unstemmed | Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus |
title_short | Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus |
title_sort | use of antimalarial agents is associated with favourable physical functioning in patients with systemic lupus erythematosus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355692/ https://www.ncbi.nlm.nih.gov/pubmed/32532059 http://dx.doi.org/10.3390/jcm9061813 |
work_keys_str_mv | AT gomezalvaro useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus AT soukkasofia useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus AT johanssonpetter useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus AT akerstromemil useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus AT emamikiasharzad useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus AT enmanyvonne useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus AT chatzidionysioukaterina useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus AT parodisioannis useofantimalarialagentsisassociatedwithfavourablephysicalfunctioninginpatientswithsystemiclupuserythematosus |